TD completes acquisition of Cowen Inc. Learn more.

$80 Million

Itamar Medical

Follow-on Offering

Bookrunner, February 2021

Itamar Medical

Itamar Medical Ltd. is a medical technology company focused on the development and commercialization of non-invasive medical devices and solutions to aid in the diagnosis of respiratory sleep disorders. The Company’s lead offering is the WatchPAT, an FDA-cleared portable, home sleep apnea test and diagnostic device that uses innovative technologies to ensure the accurate detection of sleep apnea. Itamar also offers a digital healthcare platform to facilitate the continuum of care for effective sleep apnea management with a focus on the core sleep, cardiology and direct to consumer, or DTC, markets.